By Natasha Bulowski, Canada’s National Observer, Local Journalism Initiative Reporter

Big Pharma has stepped up its lobbying game ever since the federal NDP struck a deal to prop up the Liberals’ minority government contingent on several big-ticket items — including progress on national pharmacare.

Announced last March, the Liberal-NDP agreement hinges on the federal government launching a dental care program for low-income Canadians and “continuing progress towards a universal national pharmacare program by passing a Canada Pharmacare Act by the end of 2023.”